The FDA has today authorized 23andMe to again offer genetic health risk reports to consumers. This is a big deal to the genetic testing world! Not all test will be available, only certain ones. One often requested report, the BRCA test, will not be available. But things like Alzheimer’s and Parkinson’s and eight others have been OK’d.
I have no idea how this will change general reports or prices, but the very fact that the FDA has approved 23andMe is great.
For more details, go to the 23andMe’s own blog. Blog.23andme.com